Physician

Spencer Fuller, MD, MPH

According to 2025 Medicare claims, Spencer Fuller, MD, MPH (NPI: 1124513023) practices ophthalmology in the Reno, NV market, with the plurality of this provider's patient population coming from Washoe, NV. This provider's primary affiliated billing organization is H. DHINDSA RETINA EYE CENTER, LTD. (NPI: 1568740751; TIN: 452698394) and primary practice location at 89511-9998.

Fuller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 373 traditional Medicare patients, billed 10,783 HCPCS/CPT codes, and received $398,984 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 264 prescription claims across 116 beneficiaries totaling $12,299 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 8 records totaling $362. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,938 and ending at $12,299. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$199K$399K2022 Medicare payment: $5,451 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $9,326 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $398,984 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20225076$5,451
202387123$9,326
202437310,783$398,984

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$22K2019 Drug cost: $3,938 (USD; Tot_Drug_Cst)2020 Drug cost: $18,089 (USD; Tot_Drug_Cst)2021 Drug cost: $10,585 (USD; Tot_Drug_Cst)2022 Drug cost: $22,027 (USD; Tot_Drug_Cst)2023 Drug cost: $14,479 (USD; Tot_Drug_Cst)2024 Drug cost: $12,299 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191637$3,938
202054167$18,089
202159212$10,585
2022147471$22,027
2023150344$14,479
2024116264$12,299

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more131131$126
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more189274$99
67028Injection of drug into eye100205$84
92134Imaging of retina326512$30
92250Photography of the retina279412$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate792,178$3,264
OfloxacinOfloxacin44534$550
Brimonidine TartrateBrimonidine Tartrate19953$521
Ketorolac TromethamineKetorolac Tromethamine17605$432
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat191,107$342

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$362Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Spencer Fuller, MD, MPH?

Tedicare shows public-source Medicare data for Spencer Fuller, MD, MPH (NPI 1124513023), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Spencer Fuller, MD, MPH have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Spencer Fuller, MD, MPH?

Spencer Fuller, MD, MPH is linked to H. DHINDSA RETINA EYE CENTER, LTD. (billing NPI 1568740751) in the available physician profile data.

Does Spencer Fuller, MD, MPH have Open Payments data?

Spencer Fuller, MD, MPH has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.